Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 3236 in Men With LUTS Suggestive of BPH
NCT00651807Phase 2Terminated
- Sponsor
- Organon & Co.
- Start
- Mar 2008
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing etonogestrel with Placebo (2 arms). Primary endpoints: Effect on prostate volume at 24 weeks, Effect on Lower Urinary Tract Symptoms and 8 more. Started Mar 2008; status: terminated.
02
Drugs
etonogestrel
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00651807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651807.